help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 21, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1616
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/2/660    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riancho, J. A.
Right arrow Articles by Zarrabeitia, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riancho, J. A.
Right arrow Articles by Zarrabeitia, M. T.

Submitted on July 26, 2006
Accepted on November 10, 2006

IDENTIFICATION OF AN AROMATASE HAPLOTYPE THAT IS ASSOCIATED WITH GENE EXPRESSION AND POSTMENOPAUSAL OSTEOPOROSIS

José A. Riancho*, Carmen Valero, Angel Naranjo, Dieter J. Morales, Carolina Sañudo, and María T. Zarrabeitia

Department of Internal Medicine. Hospital U.M. Valdecilla. University of Cantabria. Santander, Spain; Department of Surgery. Hospital U.M. Valdecilla. University of Cantabria. Santander, Spain; Unit of Legal Medicine. University of Cantabria. Santander, Spain

* To whom correspondence should be addressed. E-mail: rianchoj{at}unican.es.

Context. Osteoporosis has a significant genetic component. The aromatase-dependent conversion of androgenic precursors is the main source of estrogens in postmenopausal women.

Objective. To study the relationship of a set of single nucleotide polymorphisms (SNP) of the aromatase gene with osteoporosis and determine their functional influence on gene transcription.

Design, participants and methods. Case-control study including 135 women with vertebral fractures due to postmenopausal osteoporosis and 312 controls. Alleles at four SNPs situated between exons I.2 and 3 were determined by Taqman assays. Total aromatase RNA and differential allelic-specific expression were studied by RT-real time PCR in adipose tissue samples taken from 50 individuals.

Results. The SNPs studied were in strong linkage disequilibrium. A common haplotype, present in about one half of the population, was identified as being associated with an increased risk of fractures (odds ratio 1.8, 95% confidence interval 1.2-2.8, P = 0.006). There was evidence of differential allelic expression. In heterozygous individuals, transcripts bearing T alleles at rs700518 SNP (which were included in the risk haplotype) were less abundant than those with the alternative C alleles (P < 0.001). Total aromatase expression was 4 times lower in fat samples from individuals who were homozygotes for the unfavourable alleles, than in the opposite homozygotes (P = 0.007).

Conclusions. A common haplotype of aromatase associated with gene expression is also associated to the risk of osteoporotic vertebral fractures in postmenopausal women. These data are in line with the hypothesis that the aromatase-dependent synthesis of estrogens plays an important role in bone homeostasis in postmenopausal women.


Key words: aromatase • osteoporosis • single nucleotide polymorphisms • fractures • differential allelic expression







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society